Airrane Co., Ltd. (KOSDAQ:163280)
South Korea flag South Korea · Delayed Price · Currency is KRW
17,740
-250 (-1.39%)
At close: Aug 6, 2025, 3:30 PM KST

Regulus Therapeutics Revenue

Airrane had revenue of 6.01B KRW in the quarter ending March 31, 2025, with 57.76% growth. This brings the company's revenue in the last twelve months to 26.70B, up 65.37% year-over-year. In the year 2024, Airrane had annual revenue of 24.50B with 49.90% growth.

Revenue (ttm)
26.70B
Revenue Growth
+65.37%
P/S Ratio
5.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
145.02B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202424.50B8.16B49.90%
Dec 31, 202316.34B3.40B26.32%
Dec 31, 202212.94B7.60B142.13%
Dec 31, 20215.34B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition